1976
A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid Tumors
Robinson R, DeVita V, Levy H, Baron S, Hubbard S, Levine A. A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid Tumors. Journal Of The National Cancer Institute 1976, 57: 599-602. PMID: 978771, DOI: 10.1093/jnci/57.3.599.Peer-Reviewed Original ResearchConceptsSolid tumorsSerum glutamic oxaloacetic transaminaseSerum glutamic pyruvic transaminaseSeparate drug trialsObjective tumor responseDetectable serum levelsRoute of administrationChronic myelogenous leukemiaLow serum concentrationsGlutamic oxaloacetic transaminaseGlutamic pyruvic transaminasePolyriboinosinic-polyribocytidylic acidPoly I-poly CInducers of interferonCoagulation abnormalitiesSerum levelsMultiple dosesSerum concentrationsTumor responseAcute leukemiaDrug trialsBlast crisisMyelogenous leukemiaTransient elevationDrug dose
1966
Candida Meningitis
DeVITA V, UTZ J, WILLIAMS T, CARBONE P. Candida Meningitis. JAMA Internal Medicine 1966, 117: 527-535. PMID: 5906646, DOI: 10.1001/archinte.1966.03870100055011.Peer-Reviewed Original ResearchConceptsCandida meningitisChronic myelogenous leukemiaBlastic crisisMyelogenous leukemiaBlastic crisis of chronic myelogenous leukemiaCrisis of chronic myelogenous leukemiaTreated with amphotericin BAmphotericin BLaboratory featuresLaboratory findingsTreated patientsTherapeutic resultsPatientsMeningitisWhite housewifePresent reportLeukemiaWorld literatureCandidaTerminal diseaseRemissionReportsClinicDisease